Sorry, you need to enable JavaScript to visit this website.

: Efficacy and Safety of Tofacitinib in Patients With Active Ankylosing Spondylitis (AS)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study of the Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)

Category & Conditions: Immune System Diseases and Conditions
Medicine: XELJANZ®(TOFACITINIB)
ClinicalTrials.gov Identifier (NCT): NCT03502616
Protocol ID: A3921120
    Share
PrintDownload
Open Plain Language Summary Result: Click here